ARCA biopharma(ABIO) - 2024 Q1 - Quarterly Results

Exhibit 99.1 ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update ------------------------------------------------------------------------------------------------------------ • ARCA biopharma and Oruka Therapeutics announce Merger Agreement • ARCA biopharma appoints Thomas Keuer as President Westminster, CO, April 25, 2024 – ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company applying a precision medicine approach to developing genetically ...